Two Sigma Advisers’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $245K | Sell |
12,000
-57,200
| -83% | -$1.17M | ﹤0.01% | 2040 |
|
|
2025
Q1 | $1.39M | Buy |
69,200
+57,700
| +502% | +$1.16M | ﹤0.01% | 1306 |
|
|
2024
Q4 | $306K | Buy |
+11,500
| New | +$306K | ﹤0.01% | 1971 |
|
|
2024
Q2 | – | Sell |
-19,000
| Closed | -$421K | – | 2485 |
|
|
2024
Q1 | $421K | Sell |
19,000
-13,100
| -41% | -$290K | ﹤0.01% | 1944 |
|
|
2023
Q4 | $693K | Sell |
32,100
-24,400
| -43% | -$527K | ﹤0.01% | 1789 |
|
|
2023
Q3 | $954K | Sell |
56,500
-36,500
| -39% | -$616K | ﹤0.01% | 1540 |
|
|
2023
Q2 | $1.28M | Sell |
93,000
-19,300
| -17% | -$265K | ﹤0.01% | 1432 |
|
|
2023
Q1 | $2.55M | Sell |
112,300
-19,800
| -15% | -$450K | 0.01% | 1153 |
|
|
2022
Q4 | $3.11M | Sell |
132,100
-21,300
| -14% | -$501K | 0.01% | 996 |
|
|
2022
Q3 | $4M | Sell |
153,400
-1,900
| -1% | -$49.6K | 0.01% | 849 |
|
|
2022
Q2 | $3.41M | Buy |
155,300
+131,500
| +553% | +$2.89M | 0.01% | 938 |
|
|
2022
Q1 | $1.07M | Sell |
23,800
-87,700
| -79% | -$3.94M | ﹤0.01% | 1599 |
|
|
2021
Q4 | $4.78M | Buy |
111,500
+31,700
| +40% | +$1.36M | 0.01% | 789 |
|
|
2021
Q3 | $5.31M | Buy |
79,800
+29,000
| +57% | +$1.93M | 0.01% | 758 |
|
|
2021
Q2 | $3.73M | Sell |
50,800
-11,300
| -18% | -$829K | 0.01% | 999 |
|
|
2021
Q1 | $4.25M | Buy |
62,100
+37,000
| +147% | +$2.53M | 0.01% | 918 |
|
|
2020
Q4 | $1.69M | Buy |
25,100
+13,300
| +113% | +$893K | ﹤0.01% | 1341 |
|
|
2020
Q3 | $607K | Sell |
11,800
-2,500
| -17% | -$129K | ﹤0.01% | 1733 |
|
|
2020
Q2 | $539K | Buy |
14,300
+800
| +6% | +$30.2K | ﹤0.01% | 1858 |
|
|
2020
Q1 | $402K | Sell |
13,500
-900
| -6% | -$26.8K | ﹤0.01% | 1889 |
|
|
2019
Q4 | $495K | Sell |
14,400
-2,000
| -12% | -$68.8K | ﹤0.01% | 1880 |
|
|
2019
Q3 | $297K | Buy |
+16,400
| New | +$297K | ﹤0.01% | 1925 |
|